Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (يفتح نافذة جديدة)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Source‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

مفهرسة‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (يفتح نافذة جديدة)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (يفتح نافذة جديدة)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Source‎: Lancet 2018;391(10116):125-32.

مفهرسة‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (يفتح نافذة جديدة)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (يفتح نافذة جديدة)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Source‎: Am J Perinatol 2013;30(5):407-13.

مفهرسة‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (يفتح نافذة جديدة)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (يفتح نافذة جديدة)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Source‎: Am J Perinatol 2011;28(3):233-40.

مفهرسة‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (يفتح نافذة جديدة)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (يفتح نافذة جديدة)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Source‎: Lancet 2017;389(10084):2105-16.

مفهرسة‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (يفتح نافذة جديدة)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (يفتح نافذة جديدة)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Source‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

مفهرسة‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (يفتح نافذة جديدة)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (يفتح نافذة جديدة)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Source‎: Int J Gynaecol Obstet 2016;133(3):312-5.

مفهرسة‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (يفتح نافذة جديدة)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (يفتح نافذة جديدة)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Source‎: Obstet Gynecol 2007;110(6):1270-8.

مفهرسة‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (يفتح نافذة جديدة)

The use of recombinant activated FVII in postpartum hemorrhage. (يفتح نافذة جديدة)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Source‎: Clin Obstet Gynecol 2010;53(1):219-27.

مفهرسة‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (يفتح نافذة جديدة)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (يفتح نافذة جديدة)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Source‎: J Perinat Med 2011;40(1):43-9.

مفهرسة‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (يفتح نافذة جديدة)

Postpartum hemorrhage: when uterotonics and sutures fail. (يفتح نافذة جديدة)

James AH, McLintock C, Lockhart E.

Source‎: Am J Hematol 2012;87 Suppl 1:S16-22.

مفهرسة‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (يفتح نافذة جديدة)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (يفتح نافذة جديدة)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Source‎: Int J Hematol 2012;95(1):57-63.

مفهرسة‎: PubMed 22160834

DOI‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (يفتح نافذة جديدة)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (يفتح نافذة جديدة)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Source‎: J Thromb Haemost 2015;13(4):520-9.

مفهرسة‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (يفتح نافذة جديدة)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (يفتح نافذة جديدة)

Lim Y, Loo CC, Chia V, Fun W.

Source‎: Int J Gynaecol Obstet 2004;87(2):178-9.

مفهرسة‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (يفتح نافذة جديدة)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (يفتح نافذة جديدة)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Source‎: Br J Haematol 2001;114(1):174-6.

مفهرسة‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (يفتح نافذة جديدة)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (يفتح نافذة جديدة)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Source‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

مفهرسة‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (يفتح نافذة جديدة)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (يفتح نافذة جديدة)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Source‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

مفهرسة‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (يفتح نافذة جديدة)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (يفتح نافذة جديدة)

Pepas LP, Arif-Adib M, Kadir RA.

Source‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

مفهرسة‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (يفتح نافذة جديدة)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (يفتح نافذة جديدة)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Source‎: Anesth Analg 2009;109(6):1908-15.

مفهرسة‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (يفتح نافذة جديدة)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (يفتح نافذة جديدة)

Prosper SC, Goudge CS, Lupo VR.

Source‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

مفهرسة‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (يفتح نافذة جديدة)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (يفتح نافذة جديدة)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Source‎: Transfus Med 2012;22(5):344-9.

مفهرسة‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (يفتح نافذة جديدة)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (يفتح نافذة جديدة)

Bell SF, Rayment R, Collins PW, Collis RE.

Source‎: Int J Obstet Anesth 2010;19(2):218-23.

مفهرسة‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (يفتح نافذة جديدة)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (يفتح نافذة جديدة)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Source‎: Br J Anaesth 2012;108(6):984-9.

مفهرسة‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (يفتح نافذة جديدة)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (يفتح نافذة جديدة)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Source‎: J Nippon Med Sch 2014;81(2):94-6.

مفهرسة‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (يفتح نافذة جديدة)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (يفتح نافذة جديدة)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Source‎: Haemophilia 2012;18(1):25-33.

مفهرسة‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (يفتح نافذة جديدة)

Tisseel for management of traumatic postpartum haemorrhage. (يفتح نافذة جديدة)

Dhulkotia JS, Alazzam M, Galimberti A.

Source‎: Arch Gynecol Obstet 2009;279(3):437-9.

مفهرسة‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (يفتح نافذة جديدة)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (يفتح نافذة جديدة)

Moriarty KT, Premila S, Bulmer PJ.

Source‎: BJOG 2008;115(6):793-5.

مفهرسة‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (يفتح نافذة جديدة)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (يفتح نافذة جديدة)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Source‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

مفهرسة‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (يفتح نافذة جديدة)

Fibrin sealant for management of complicated obstetric lacerations. (يفتح نافذة جديدة)

Whiteside JL, Asif RB, Novello RJ.

Source‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

مفهرسة‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (يفتح نافذة جديدة)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (يفتح نافذة جديدة)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Source‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

مفهرسة‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (يفتح نافذة جديدة)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (يفتح نافذة جديدة)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Source‎: Int J Obstet Anesth 2011;20(4):293-8.

مفهرسة‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (يفتح نافذة جديدة)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (يفتح نافذة جديدة)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Source‎: Obstet Gynecol Surv 2012;67(7):426-35.

مفهرسة‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (يفتح نافذة جديدة)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (يفتح نافذة جديدة)

Karlsson O, Jeppsson A, Hellgren M.

Source‎: Int J Obstet Anesth 2014;23(1):10-7.

مفهرسة‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (يفتح نافذة جديدة)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (يفتح نافذة جديدة)

Levy JH, Welsby I, Goodnough LT.

Source‎: Transfusion 2014;54(5):1389-405.

مفهرسة‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (يفتح نافذة جديدة)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (يفتح نافذة جديدة)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Source‎: Int J Obstet Anesth 2015;24(2):174-9.

مفهرسة‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (يفتح نافذة جديدة)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (يفتح نافذة جديدة)

Solomon C, Collis RE, Collins PW.

Source‎: Br J Anaesth 2012;109(6):851-63.

مفهرسة‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (يفتح نافذة جديدة)